Cognitive and Performance Enhancing Compositions for Diverse Applications
Legal Citation
Summary of the Inventive Concept
The present inventive concept relates to novel applications of specialized immunonutrition supplements, originally developed for treating surgery-induced cachexia, in diverse fields such as enhancing cognitive function, reducing anxiety, improving athletic performance, treating depression, and enhancing mental clarity and focus.
Background and Problem Solved
The original patent disclosed compositions and methods for treating or preventing surgery-induced cachexia and/or expression of myeloid-derived suppressor cells and pro-inflammatory cytokines. However, the patent's scope was limited to the specific application of treating surgery-induced cachexia. The present inventive concept addresses the need for novel applications of these specialized immunonutrition supplements in other industries and fields, leveraging their potential benefits for diverse populations.
Detailed Description of the Inventive Concept
The inventive concept encompasses systems and methods for administering specialized immunonutrition supplements comprising L-arginine, omega-3 fatty acids, vitamin A, and dietary nucleotides to individuals in need of cognitive, performance, or emotional enhancement. The supplements are tailored to provide specific daily doses of each component, as outlined in the new claims. For instance, the composition for enhancing cognitive function in individuals with ADHD includes a daily dose of 5-30g of L-arginine, while the composition for reducing symptoms of anxiety in individuals undergoing a stressful event includes a daily dose of 1.0-5.0g of eicosapentaenoic acid and docosahexaenoic acid in total.
Novelty and Inventive Step
The novelty of the present inventive concept lies in the unexpected application of specialized immunonutrition supplements, originally developed for treating surgery-induced cachexia, in diverse fields such as cognitive enhancement, anxiety reduction, athletic performance improvement, depression treatment, and mental clarity and focus enhancement. The inventive step resides in the recognition of the supplements' potential benefits in these new areas and the tailoring of the compositions and methods to address specific needs and populations.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept may include varying the daily doses of each component, combining the supplements with other nutrients or compounds, or developing new formulations for specific applications. Variations may also include adapting the compositions and methods for use in different populations, such as children or elderly individuals, or for addressing specific health conditions, such as chronic fatigue syndrome or post-traumatic stress disorder.
Potential Commercial Applications and Market
The present inventive concept has significant commercial potential in various industries, including pharmaceuticals, nutraceuticals, sports nutrition, and mental health. The target markets include individuals with ADHD, athletes seeking performance enhancement, individuals experiencing anxiety or depression, and those seeking to improve their mental clarity and focus. The inventive concept's broad applicability and potential benefits position it for significant market impact and growth.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Nutritional supplementation, immunonutrition, and medical treatment strategies, with expertise in biochemical composition design and targeted nutritional interventions
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced training in nutrition science, pharmacology, or biochemistry, possessing knowledge of supplement formulation, understanding of nutrient interactions, and ability to recognize potential alternative applications of established nutritional compositions
Obviousness Rationale
A PHOSITA would recognize that the specialized immunonutrition supplement's core components (L-arginine, omega-3 fatty acids, vitamin A, dietary nucleotides) have broad physiological effects beyond surgical cachexia treatment. The systematic exploration of these nutrients' potential in cognitive, emotional, and performance domains represents a predictable extension of the source patent's foundational research, utilizing known dosage ranges and established nutritional principles.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,525 |
|---|---|
| Title | Treatment or prevention of surgery-induced cachexia and/or expression of myeloid-derived suppressor cells and pro-inflammatory cytokines |
| Assignee(s) | SOCIÉTÉ DES PRODUITS NESTLÉ S.A. |